A.M.M. Vernooij-van Langen

Novel strategies in newborn screening for cystic fibrosis: a prospective controlled study

A.M.M. Vernooij-van Langen, J.G. Loeber, Bert Elvers et al. · Thorax · 2012 · 58 citations · Full text

Medicine, Child Health, Pediatrics +15

Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data

C.P.B. van der Ploeg, M. Elske van den Akker‐van Marle, A.M.M. Vernooij-van Langen et al. · Journal of Cystic Fibrosis · 2014 · 34 citations · Full text

Pharmacy, Pediatrics, Pharmacoeconomics +14

Parental knowledge reduces long term anxiety induced by false-positive test results after newborn screening for cystic fibrosis

A.M.M. Vernooij-van Langen, Sylvia van der Pal, A.J.T. Reijntjens et al. · Molecular Genetics and Metabolism Reports · 2014 · 21 citations · Full text

Public Health, Child Health, Pediatrics +12

The influence of sex, gestational age, birth weight, blood transfusion, and timing of the heel prick on the pancreatitis‐associated protein concentration in newborn screening for cystic fibrosis

A.M.M. Vernooij-van Langen, J.G. Loeber, Bert Elvers et al. · Journal of Inherited Metabolic Disease · 2012 · 13 citations

Medicine, Obstetrics, Pediatrics +17

Differences in clinical condition and genotype at time of diagnosis of cystic fibrosis by newborn screening or by symptoms

A.M.M. Vernooij-van Langen, Frederick L.G.R. Gerzon, J.G. Loeber et al. · Molecular Genetics and Metabolism · 2014 · 10 citations

Medicine, Genetics, Pediatrics +15